BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 32991968)

  • 1. CCR5 tyrosine sulfation heterogeneity generates cell surface receptor subpopulations with different ligand binding properties.
    Scurci I; Akondi KB; Pinheiro I; Paolini-Bertrand M; Borgeat A; Cerini F; Hartley O
    Biochim Biophys Acta Gen Subj; 2021 Jan; 1865(1):129753. PubMed ID: 32991968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Homogeneous sulfopeptides and sulfoproteins: synthetic approaches and applications to characterize the effects of tyrosine sulfation on biochemical function.
    Stone MJ; Payne RJ
    Acc Chem Res; 2015 Aug; 48(8):2251-61. PubMed ID: 26196117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allovalency observed by transferred NOE: interactions of sulfated tyrosine residues in the N-terminal segment of CCR5 with the CCL5 chemokine.
    Kessler N; Akabayov SR; Moseri A; Cohen LS; Sakhapov D; Bolton D; Fridman B; Kay LE; Naider F; Anglister J
    FEBS J; 2021 Mar; 288(5):1648-1663. PubMed ID: 32814359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arylsulfatases and neuraminidases modulate engagement of CCR5 by chemokines by removing key electrostatic interactions.
    Pinheiro I; Calo N; Paolini-Bertrand M; Hartley O
    Sci Rep; 2024 Jan; 14(1):292. PubMed ID: 38167636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arrestin Recruitment to C-C Chemokine Receptor 5: Potent C-C Chemokine Ligand 5 Analogs Reveal Differences in Dependence on Receptor Phosphorylation and Isoform-Specific Recruitment Bias.
    Martins E; Brodier H; Rossitto-Borlat I; Ilgaz I; Villard M; Hartley O
    Mol Pharmacol; 2020 Nov; 98(5):599-611. PubMed ID: 32943494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular anatomy of CCR5 engagement by physiologic and viral chemokines and HIV-1 envelope glycoproteins: differences in primary structural requirements for RANTES, MIP-1 alpha, and vMIP-II Binding.
    Navenot JM; Wang ZX; Trent JO; Murray JL; Hu QX; DeLeeuw L; Moore PS; Chang Y; Peiper SC
    J Mol Biol; 2001 Nov; 313(5):1181-93. PubMed ID: 11700073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-Affinity Binding of Chemokine Analogs that Display Ligand Bias at the HIV-1 Coreceptor CCR5.
    Rico CA; Berchiche YA; Horioka M; Peeler JC; Lorenzen E; Tian H; Kazmi MA; Fürstenberg A; Gaertner H; Hartley O; Sakmar TP; Huber T
    Biophys J; 2019 Sep; 117(5):903-919. PubMed ID: 31421836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pattern and temporal sequence of sulfation of CCR5 N-terminal peptides by tyrosylprotein sulfotransferase-2: an assessment of the effects of N-terminal residues.
    Jen CH; Moore KL; Leary JA
    Biochemistry; 2009 Jun; 48(23):5332-8. PubMed ID: 19402700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sialylated O-glycans and sulfated tyrosines in the NH2-terminal domain of CC chemokine receptor 5 contribute to high affinity binding of chemokines.
    Bannert N; Craig S; Farzan M; Sogah D; Santo NV; Choe H; Sodroski J
    J Exp Med; 2001 Dec; 194(11):1661-73. PubMed ID: 11733580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation and Analysis of N-Terminal Chemokine Receptor Sulfopeptides Using Tyrosylprotein Sulfotransferase Enzymes.
    Seibert C; Sanfiz A; Sakmar TP; Veldkamp CT
    Methods Enzymol; 2016; 570():357-88. PubMed ID: 26921955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Site-selective solid-phase synthesis of a CCR5 sulfopeptide library to interrogate HIV binding and entry.
    Liu X; Malins LR; Roche M; Sterjovski J; Duncan R; Garcia ML; Barnes NC; Anderson DA; Stone MJ; Gorry PR; Payne RJ
    ACS Chem Biol; 2014 Sep; 9(9):2074-81. PubMed ID: 24963694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Synthesis of Sulfated CCR5 Peptide Surrogates and their Use to Study Receptor-Ligand Interactions.
    Naider F; Anglister J
    Protein Pept Lett; 2018; 25(12):1124-1136. PubMed ID: 30381052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tyrosine sulfation of CCR5 N-terminal peptide by tyrosylprotein sulfotransferases 1 and 2 follows a discrete pattern and temporal sequence.
    Seibert C; Cadene M; Sanfiz A; Chait BT; Sakmar TP
    Proc Natl Acad Sci U S A; 2002 Aug; 99(17):11031-6. PubMed ID: 12169668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CC chemokine receptor 5 (CCR5) desensitization: cycling receptors accumulate in the trans-Golgi network.
    Escola JM; Kuenzi G; Gaertner H; Foti M; Hartley O
    J Biol Chem; 2010 Dec; 285(53):41772-80. PubMed ID: 21041313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The chemokines CCL5 and CXCL12 exhibit high-affinity binding to N-terminal peptides of the non-cognate receptors CXCR4 and CCR5, respectively.
    Kessler N; Akabayov SR; Cohen LS; Scherf T; Naider F; Anglister J
    FEBS J; 2024 Feb; 291(3):458-476. PubMed ID: 37997026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chapter 7. Tyrosine sulfation of HIV-1 coreceptors and other chemokine receptors.
    Choe H; Farzan M
    Methods Enzymol; 2009; 461():147-70. PubMed ID: 19480918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "Glyco-sulfo barcodes" regulate chemokine receptor function.
    Verhallen L; Lackman JJ; Wendt R; Gustavsson M; Yang Z; Narimatsu Y; Sørensen DM; Lafferty KM; Gouwy M; Marques PE; Hjortø GM; Rosenkilde MM; Proost P; Goth CK
    Cell Mol Life Sci; 2023 Feb; 80(2):55. PubMed ID: 36729338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allosteric effects of antagonists on signalling by the chemokine receptor CCR5.
    Haworth B; Lin H; Fidock M; Dorr P; Strange PG
    Biochem Pharmacol; 2007 Sep; 74(6):891-7. PubMed ID: 17669370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. G protein subtype-specific signaling bias in a series of CCR5 chemokine analogs.
    Lorenzen E; Ceraudo E; Berchiche YA; Rico CA; Fürstenberg A; Sakmar TP; Huber T
    Sci Signal; 2018 Oct; 11(552):. PubMed ID: 30327411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aminooxypentane-RANTES induces CCR5 internalization but inhibits recycling: a novel inhibitory mechanism of HIV infectivity.
    Mack M; Luckow B; Nelson PJ; Cihak J; Simmons G; Clapham PR; Signoret N; Marsh M; Stangassinger M; Borlat F; Wells TN; Schlöndorff D; Proudfoot AE
    J Exp Med; 1998 Apr; 187(8):1215-24. PubMed ID: 9547333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.